Ridgefield-based Boehringer Ingelheim Pharmaceuticals has agreed to pay $650 million to settle thousands of claims that an antistroke medication caused excessive bleeding.
May 28, 2014 at 12:55 AM
1 minute read
Ridgefield-based Boehringer Ingelheim Pharmaceuticals has agreed to pay $650 million to settle thousands of claims that an antistroke medication caused excessive bleeding.
A federal lawsuit had been pending on a multidistrict litigation docket in Illinois. Meanwhile, consolidated state claims had been filed in California, Connecticut, Delaware and Missouri.
Presented by BigVoodoo
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
